Amiselimod: A New Oral Agent in the Treatment of Multiple Sclerosis
Journal Title: UNKNOWN - Year 2017, Vol 23, Issue 3
Abstract
.
Authors and Affiliations
Ahmed Serkan Emekli
Keywords
Related Articles
- EP ID EP276707
- DOI 10.4274/tnd.90018
- Views 77
- Downloads 0
Assessment of Trunk Control in Patients with Neuromuscular Diseases: Validity and Reliability of the Trunk Impairment Scale
Objective: The aim of our study was to determine the reliability and validity of the Trunk Impairment Scale (TIS) in patients with adult neuromuscular diseases (NMD). Materials and Methods: Sixty-six patients with NMD pa...
The Evaluation of Botulinum Toxin Injection Effect for Poststroke Spasticity Treatment
Objective: In this study we aimed to evaluate the effectivity of treatment with the botulinum toxin-type A (BTX-A) on spasticity, spasticity-related pain, and the daily living activities in post-stroke patients with uppe...
Shift in Time Zone: The Biologic Clock and Neurology
.
Correlation of Prechtl Qualitative Assessment of General Movement Analysis with Neurological Evaluation: The Importance of Inspection in Infants
Objective: Motor development is at the forefront of evaluation of neurodevelopmental functions in the first 6 months of life. Significant spontaneous movement patterns of infants are called general movements. General mov...
Intravenous Thrombolytic Therapy in Acute Ischemic Stroke: The Experience of Kütahya
Objective: Stroke is a serious cause of mortality and disability. The caregiver of the patients may be adversely affected by this situation as well. In addition, stroke has a great economic burden on healthcare. Signific...